Previous Close | 0.2900 |
Open | 0.2100 |
Bid | 0.0000 |
Ask | 0.3900 |
Strike | 47.50 |
Expire Date | 2024-10-18 |
Day's Range | 0.2100 - 0.2900 |
Contract Range | N/A |
Volume | |
Open Interest | 3 |
The latest trading day saw Astrazeneca (AZN) settling at $78.38, representing a -0.66% change from its previous close.
WILMINGTON, Del., September 20, 2024--FLUMIST® has been approved in the US as the only self-administered influenza vaccine. FLUMIST, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age.1
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.